HCC
NOV icon

Hirtle Callaghan & Co’s NOV NOV Stock Holding History

Hirtle Callaghan & Co’s Portfolio NOV Stock Details NOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-5,237
Closed -$343K – 257
2014
Q4 		$343K Hold
5,237
– – 0.08% 142
2014
Q3 		$399K Hold
5,237
– – 0.07% 126
2014
Q2 		$431K Sell
5,237
-576
-10% -$42.9K 0.06% 154
2014
Q1 		$408K Sell
5,813
-19
-0.3% -$1.3K 0.07% 148
2013
Q4 		$418K Buy
5,832
+340
+6% +$24.7K 0.06% 151
2013
Q3 		$387K Buy
+5,492
New +$368K 0.06% 151

Other funds holding NOV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Hirtle Callaghan & Co's NOV Position: Q1 2015 in Review

Hirtle Callaghan & Co sold out of NOV (NOV) in Q1 2015, closing a stake of 5,237 shares — an estimated $343K sold.

Hirtle Callaghan & Co first reported a position in NOV in Q3 2013 and held it in 6 quarters. The position peaked at $431K in Q2 2014. 826 funds tracked by Wall St. Rank hold NOV as of Q1 2015.

  • Hirtle Callaghan & Co reported no remaining NOV position as of Q1 2015 after selling out during the quarter.
  • Hirtle Callaghan & Co sold 5,237 NOV shares in Q1 2015, an estimated $343K.
  • Hirtle Callaghan & Co first reported a position in NOV in Q3 2013 and held it in 6 quarters.
  • Hirtle Callaghan & Co's NOV position peaked at $431K in Q2 2014.
  • 826 funds tracked by Wall St. Rank held NOV as of Q1 2015.

Based on Hirtle Callaghan & Co's 13F filing for Q1 2015, filed 15 May 2015.